As far as 'better' is concerned, BIT225, already proven safe in...

First 140 Last

Share
Profile

Follow
Footmax

14,091 Posts.

2410

05/10/22

11:02

Post #: 64037296
Share

As far as 'better' is concerned, BIT225, already proven safe in immune compromised individuals, if fully proven and tested, has the potential to be extremely low cost and very easy and fast to move into a productivity and be distributed on a world scale.

If BIT can prove this in its latest trials, then they have a chance of getting it picked up by BP.

Unfortunately, the amount of research going on, may mean that BIT won't e alone delivering this result. Therein lies a danger point for BIT.

Originally posted by mxdbg: ↑

Regardless of public and political sentiment, covid, like the occasional strain of flu, is still killing a fair portion of the world population. It appears to me that the USA'ns have finally caught up their medical establishments enough to be able to treat, at least, the well heeled, and that sentiment is influencing our various media's. Have a look at the numbers of people killed in just QLD this last year and expect to be shocked. All's quiet across the media, but that is not the reality. Our slowdown policy worked, and we have the facilities to treat those on Death's door, but that is about it. Luckily, the new variants are currently less lethal across the population, but that could, IMO, lead to a false sense of security.

The available treatments are very expensive and carry a high level of either, danger to the patient or viral mutation and escape. This is due mainly to mutations in the spike, which is not BIT's target. Some treatments are killing some of the virus, but that appears to be all they do. Other treatments are focused on preventing death by one's own immune system. I have yet to see a treatment that slows and prevents virus replication while also negating the cytokine storm, as is the focus of Biotron's technology.

As far as 'better' is concerned, BIT225, already proven safe in immune compromised individuals, if fully proven and tested, has the potential to be extremely low cost and very easy and fast to move into a productivity and be distributed on a world scale.

Expand

BIT Price at posting: 5.0¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

What's causing the cost-of-living crisis, and how to navigate it

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

TLG

Talga Group wins key permit for flagship graphite mine in Sweden